ARCHIVES

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

Center Directors, NCI Staff Agree- They Have Problems

November 26, 1976

Chemopreventive Phase I, Preclinical Studies Concept Approved

May 13, 1983

Obama Signs Law Authorizing $126 Million Over 10 Years for Pediatric Research

April 11, 2014

Annual Report to the Nation Shows Decline In Overall Cancer Death Rates

January 11, 2013

In Brief: Nurses Association Endorses Clinton-Gore; Levin Heads New Society For Neuro-Oncology

June 28, 1996

NCI Virus Program Has “Important Extension of Virology” as New Approach To Etiology

April 23, 1976